The DNA methylation profiling clearly distinguishes IDH mutant gliomas from their wild type counterparts by the glioma CpG island methylator phenotype (G-CIMP) (Turcan et al., 2012; Wiestler et al., 2014; Noushmehr et al., 2010). This evidence concerns the gene IDH1 and central nervous system cancer.